EUVIMEDEUVIMED entdecken
Crossref

Discovery of myrsinane-type Euphorbia diterpene derivatives through a skeleton conversion strategy from lathyrane diterpene for the treatment of Alzheimer's disease

Yao Xiao, Yang Zhang, Wan-Sheng Ji, Xiao-Nan Jia, Lian-Hai Shan, Xiaohuan Li, Yan-Jun Liu, Ting Jiang, Feng Gao

Bioorganic Chemistry · 2023

DOI: 10.1016/j.bioorg.2023.106595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023. Verfasst von Yao Xiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University,…. Hauptthemen laut MEDLINE: Euphorbia, Neuroblastoma, Alzheimer Disease, Diterpenes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of novel myrsinane-type Euphorbia diterpene derivatives (1-37) were synthesized from the abundant natural lathyrane-type Euphorbia factor L3, using a multi-step chemical process guided by a bioinspired skeleton conversion strategy, with the aim of discovering potential anti-Alzheimer's disease (AD) bioactive lead compounds. The synthesis process involved a concise reductive olefin coupling reaction through an intramolecular Michael addition with a free radical, followed by a visible-light-triggered regioselective cyclopropane ring-opening. The cholinesterase inhibitory and neuroprotective activities of the synthesized myrsinane derivatives were evaluated. Most of the compounds showed moderate to strong potency, highlighting the importance of ester groups in Euphorbia diterpene. In particular, derivative 37 displayed the most potent acetylcholinesterase (AChE) inhibition, with an IC50 value of 8.3 μM, surpassing that of the positive control, tacrine. Additionally, 37 also showed excellent neuroprotective effect against H2O2-induced injury in SH-SY5Y cells, with a cell viability rate of 124.2% at 50 μM, which was significantly higher than that of the model group (viability rate 52.1%). Molecular docking, reactive oxygen species (ROS) analysis, immunofluorescence, and immunoblotting were performed to investigate the mechanism of action of myrsinane derivative 37. The results indicated that derivative 37 may be a promising myrsinane-type multi-functional lead compound for the treatment of Alzheimer's disease. Furthermore, a preliminary SAR analysis was performed to study the acetylcholinesterase inhibitory and neuroprotective activities of these diterpenes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EuphorbiaNeuroblastomaAlzheimer DiseaseDiterpenesNeuroprotective AgentsHumansAcetylcholinesteraseMolecular Docking SimulationHydrogen PeroxideSkeletonCholinesterase InhibitorsMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

Euphorbia diterpeneMyrsinaneNeuroprotective activitySkeleton conversionacetylcholinesterase (AChE) inhibition

Substanzen

lathyraneAcetylcholinesteraseHydrogen PeroxideDiterpenesCholinesterase InhibitorsNeuroprotective Agents

Autor:innen und Institutionen

  • Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, PR China.
  • The Center of Gastrointestinal and Minimally Invasive Surgery, Department of General Surgery, The Third People's Hospital of Chengdu, The Affiliated Hospital of Southwest Jiaotong University, Chengdu 610031, PR China. E…
  • Department of Pharmacy, The First Afflicted Hospital of Chengdu Medical College, Chengdu 610500, PR China. Electronic address: jiangtingtina@163.com.
  • Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, PR China. Electronic address: gaof@swjtu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiao, Y., Zhang, Y., Ji, W. S., Jia, X. N., Shan, L. H., Li, X., Liu, Y. J., Jiang, T., & Gao, F. (2023). Discovery of myrsinane-type Euphorbia diterpene derivatives through a skeleton conversion strategy from lathyrane diterpene for the treatment of Alzheimer's disease. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2023.106595

Vancouver

Xiao Y, Zhang Y, Ji WS, Jia XN, Shan LH, Li X, et al. Discovery of myrsinane-type Euphorbia diterpene derivatives through a skeleton conversion strategy from lathyrane diterpene for the treatment of Alzheimer's disease. Bioorganic Chemistry. 2023. doi:10.1016/j.bioorg.2023.106595

BibTeX
@article{Xiao2023,
  author = {Xiao, Yao and Zhang, Yang and Ji, Wan-Sheng and Jia, Xiao-Nan and Shan, Lian-Hai and Li, Xiaohuan and Liu, Yan-Jun and Jiang, Ting and Gao, Feng},
  title = {Discovery of myrsinane-type Euphorbia diterpene derivatives through a skeleton conversion strategy from lathyrane diterpene for the treatment of Alzheimer's disease},
  journal = {Bioorganic Chemistry},
  year = {2023},
  doi = {10.1016/j.bioorg.2023.106595}
}
Kostenlos starten →